United States (US) Gadolinium-based Contrast Media Market (2025-2031) | Industry, Size & Revenue, Forecast, Share, Segmentation, Trends, Value, Analysis, Competitive Landscape, Outlook, Growth, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Gadolinium-based Contrast Media Market - Industry Life Cycle

3.4 United States (US) Gadolinium-based Contrast Media Market - Porter's Five Forces

3.5 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume Share, By Modality, 2021 & 2031F

3.7 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume Share, By Indication, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases requiring diagnostic imaging procedures

4.2.2 Technological advancements in medical imaging techniques

4.2.3 Growing demand for accurate and early diagnosis in healthcare

4.3 Market Restraints

4.3.1 Regulatory concerns and stringent guidelines governing the use of gadolinium-based contrast media

4.3.2 Potential health risks associated with gadolinium retention in the body

6.1 United States (US) Gadolinium-based Contrast Media Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume, By Extracellular agents, 2021- 2031F

6.1.4 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume, By Blood pool agents, 2021- 2031F

6.1.5 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume, By Hepatobiliary agents, 2021- 2031F

6.2 United States (US) Gadolinium-based Contrast Media Market, By Modality

6.2.1 Overview and Analysis

6.2.2 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume, By MRI, 2021- 2031F

6.2.3 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume, By MRA, 2021- 2031F

6.3 United States (US) Gadolinium-based Contrast Media Market, By Indication

6.3.1 Overview and Analysis

6.3.2 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume, By Cardiovascular, 2021- 2031F

6.3.3 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume, By Neurology, 2021- 2031F

6.3.4 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume, By Cancer, 2021- 2031F

6.3.5 United States (US) Gadolinium-based Contrast Media Market Revenues & Volume, By Others (Musculoskeletal), 2021- 2031F

7.1 United States (US) Gadolinium-based Contrast Media Market Export to Major Countries

7.2 United States (US) Gadolinium-based Contrast Media Market Imports from Major Countries

8.1 Number of diagnostic imaging procedures performed using gadolinium-based contrast media

8.2 Adoption rate of new gadolinium-based contrast media products in the market

8.3 Investment in research and development for developing safer alternatives to gadolinium-based contrast media

9.1 United States (US) Gadolinium-based Contrast Media Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Gadolinium-based Contrast Media Market Opportunity Assessment, By Modality, 2021 & 2031F

9.3 United States (US) Gadolinium-based Contrast Media Market Opportunity Assessment, By Indication, 2021 & 2031F

10.1 United States (US) Gadolinium-based Contrast Media Market Revenue Share, By Companies, 2024

10.2 United States (US) Gadolinium-based Contrast Media Market Competitive Benchmarking, By Operating and Technical Parameters